Seoul, South Korea

Young Joo Shin


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Young Joo Shin: Innovator in Corneal Endothelial Treatment

Introduction

Young Joo Shin is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of ophthalmology, particularly in the treatment of corneal endothelial wounds. His innovative approach has the potential to improve the healing process for patients suffering from such conditions.

Latest Patents

Young Joo Shin holds a patent for a pharmaceutical composition aimed at treating corneal endothelial wounds. The patent, titled "Pharmaceutical composition for treatment of corneal endothelial wounds containing angiogenin," describes a composition that includes angiogenin as an effective ingredient. This invention highlights a new topical therapeutic use of angiogenin, which is known to be involved in angiogenesis. The composition activates the PI3K/Akt/eNOS pathway in ocular corneal endothelium, promoting the migration and proliferation of corneal endothelial cells that cannot self-proliferate. This advancement is crucial for the prevention and treatment of corneal endothelial cell wounds.

Career Highlights

Throughout his career, Young Joo Shin has been associated with prominent institutions. He has worked with Chung Ang University Industry Academic Cooperation and Chungbuk National University Industry-Academic Cooperation Foundation. His work in these organizations has allowed him to collaborate with other experts in the field and contribute to significant research and development.

Collaborations

Young Joo Shin has collaborated with notable colleagues, including Jae Chan Kim and Kyoung Woo Kim. These partnerships have facilitated the advancement of research in the area of corneal treatments and have led to innovative solutions for ocular health.

Conclusion

Young Joo Shin's contributions to the field of ophthalmology, particularly through his patent on angiogenin for corneal endothelial wounds, showcase his dedication to improving patient outcomes. His work continues to inspire advancements in medical treatments and highlights the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…